Myroslav Zapukhlyak

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Fast organ-of-origin classification for digital pathology quality control.

Fast organ-of-origin classification for digital pathology quality control.

Journal: Journal of pathology informatics
Published: February 18, 2026

Diversity over scale: Whole-slide image variety enables H&E foundation model training with fewer patches.

Diversity over scale: Whole-slide image variety enables H&E foundation model training with fewer patches.

Journal: Journal of pathology informatics
Published: November 18, 2025

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.

Journal: Leukemia
Published: June 16, 2023

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma.

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma.

Journal: Frontiers in immunology
Published: May 10, 2023

Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma.

Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma.

Journal: Cancers
Published: February 11, 2023

Molecular profiling of EBV associated diffuse large B-cell lymphoma.

Molecular profiling of EBV associated diffuse large B-cell lymphoma.

Journal: Leukemia
Published: September 21, 2022

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma.

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma.

Journal: Leukemia
Published: June 17, 2022

Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial.

Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial.

Journal: Leukemia
Published: November 05, 2021

Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age.

Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age.

Journal: Nature communications
Published: October 05, 2021

The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditions.

The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditions.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 06, 2020

Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL.

Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL.

Journal: Blood
Published: October 06, 2020

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma.

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma.

Journal: Nature communications
Published: September 21, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026